Patent Deal Clears Actavis' Zohydro Generic For 2029
Actavis Laboratories FL Inc. will be able to launch its generic version of the hydrocodone-based painkiller Zohydro ER in March 2029, Pernix Therapeutics Holdings Inc. announced Monday as part of a...To view the full article, register now.
Already a subscriber? Click here to view full article